[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cell and Gene Therapy Supply Chain and Logistics Market Research Report 2024(Status and Outlook)

April 2024 | 137 pages | ID: G66FB8C190FAEN
Bosson Research

US$ 2,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

This report provides a deep insight into the global Cell and Gene Therapy Supply Chain and Logistics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell and Gene Therapy Supply Chain and Logistics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell and Gene Therapy Supply Chain and Logistics market in any manner.

Global Cell and Gene Therapy Supply Chain and Logistics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Be The Match BioTherapies

Biocair

Marken

World Courier

MAK-SYSTEM

Cryoport

Brooks Life Sciences

Clarkston Consulting

Hypertrust Patient Data Care

Haemonetics

MasterControl

TraceLink

SAVSU Technologies

TrakCel

Title21 Health Solutions

sedApta Group

Vineti

Stafa Cellular Therapy

Thermo Fisher Scientific

McKesson

BioLife Solutions

Market Segmentation (by Type)

Ordering and Scheduling Services

Sample Collection Services

Logistics Services

Post Treatment Follow-Up Services

Market Segmentation (by Application)

Biobank

Cell Therapy Lab

Hospital

Research Institute

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Cell and Gene Therapy Supply Chain and Logistics Market
  • Overview of the regional outlook of the Cell and Gene Therapy Supply Chain and Logistics Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy Supply Chain and Logistics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Cell and Gene Therapy Supply Chain and Logistics
1.2 Key Market Segments
  1.2.1 Cell and Gene Therapy Supply Chain and Logistics Segment by Type
  1.2.2 Cell and Gene Therapy Supply Chain and Logistics Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS MARKET COMPETITIVE LANDSCAPE

3.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Company (2019-2024)
3.2 Cell and Gene Therapy Supply Chain and Logistics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Cell and Gene Therapy Supply Chain and Logistics Market Size Sites, Area Served, Product Type
3.4 Cell and Gene Therapy Supply Chain and Logistics Market Competitive Situation and Trends
  3.4.1 Cell and Gene Therapy Supply Chain and Logistics Market Concentration Rate
  3.4.2 Global 5 and 10 Largest Cell and Gene Therapy Supply Chain and Logistics Players Market Share by Revenue
  3.4.3 Mergers & Acquisitions, Expansion

4 CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS VALUE CHAIN ANALYSIS

4.1 Cell and Gene Therapy Supply Chain and Logistics Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 Mergers & Acquisitions
  5.5.2 Expansions
  5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies

6 CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type (2019-2024)
6.3 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Type (2019-2024)

7 CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size (M USD) by Application (2019-2024)
7.3 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Application (2019-2024)

8 CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS MARKET SEGMENTATION BY REGION

8.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region
  8.1.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region
  8.1.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Region
8.2 North America
  8.2.1 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Be The Match BioTherapies
  9.1.1 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.1.2 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics SWOT Analysis
  9.1.5 Be The Match BioTherapies Business Overview
  9.1.6 Be The Match BioTherapies Recent Developments
9.2 Biocair
  9.2.1 Biocair Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.2.2 Biocair Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.2.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics SWOT Analysis
  9.2.5 Biocair Business Overview
  9.2.6 Biocair Recent Developments
9.3 Marken
  9.3.1 Marken Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.3.2 Marken Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.3.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics SWOT Analysis
  9.3.5 Marken Business Overview
  9.3.6 Marken Recent Developments
9.4 World Courier
  9.4.1 World Courier Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.4.2 World Courier Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.4.4 World Courier Business Overview
  9.4.5 World Courier Recent Developments
9.5 MAK-SYSTEM
  9.5.1 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.5.2 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.5.4 MAK-SYSTEM Business Overview
  9.5.5 MAK-SYSTEM Recent Developments
9.6 Cryoport
  9.6.1 Cryoport Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.6.2 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.6.4 Cryoport Business Overview
  9.6.5 Cryoport Recent Developments
9.7 Brooks Life Sciences
  9.7.1 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.7.2 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.7.4 Brooks Life Sciences Business Overview
  9.7.5 Brooks Life Sciences Recent Developments
9.8 Clarkston Consulting
  9.8.1 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.8.2 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.8.3 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.8.4 Clarkston Consulting Business Overview
  9.8.5 Clarkston Consulting Recent Developments
9.9 Hypertrust Patient Data Care
  9.9.1 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.9.2 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.9.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.9.4 Hypertrust Patient Data Care Business Overview
  9.9.5 Hypertrust Patient Data Care Recent Developments
9.10 Haemonetics
  9.10.1 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.10.2 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.10.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.10.4 Haemonetics Business Overview
  9.10.5 Haemonetics Recent Developments
9.11 MasterControl
  9.11.1 MasterControl Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.11.2 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.11.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.11.4 MasterControl Business Overview
  9.11.5 MasterControl Recent Developments
9.12 TraceLink
  9.12.1 TraceLink Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.12.2 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.12.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.12.4 TraceLink Business Overview
  9.12.5 TraceLink Recent Developments
9.13 SAVSU Technologies
  9.13.1 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.13.2 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.13.3 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.13.4 SAVSU Technologies Business Overview
  9.13.5 SAVSU Technologies Recent Developments
9.14 TrakCel
  9.14.1 TrakCel Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.14.2 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.14.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.14.4 TrakCel Business Overview
  9.14.5 TrakCel Recent Developments
9.15 Title21 Health Solutions
  9.15.1 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.15.2 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.15.3 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.15.4 Title21 Health Solutions Business Overview
  9.15.5 Title21 Health Solutions Recent Developments
9.16 sedApta Group
  9.16.1 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.16.2 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.16.3 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.16.4 sedApta Group Business Overview
  9.16.5 sedApta Group Recent Developments
9.17 Vineti
  9.17.1 Vineti Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.17.2 Vineti Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.17.3 Vineti Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.17.4 Vineti Business Overview
  9.17.5 Vineti Recent Developments
9.18 Stafa Cellular Therapy
  9.18.1 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.18.2 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.18.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.18.4 Stafa Cellular Therapy Business Overview
  9.18.5 Stafa Cellular Therapy Recent Developments
9.19 Thermo Fisher Scientific
  9.19.1 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.19.2 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.19.3 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.19.4 Thermo Fisher Scientific Business Overview
  9.19.5 Thermo Fisher Scientific Recent Developments
9.20 McKesson
  9.20.1 McKesson Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.20.2 McKesson Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.20.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.20.4 McKesson Business Overview
  9.20.5 McKesson Recent Developments
9.21 BioLife Solutions
  9.21.1 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Basic Information
  9.21.2 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product Overview
  9.21.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product Market Performance
  9.21.4 BioLife Solutions Business Overview
  9.21.5 BioLife Solutions Recent Developments

10 CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS REGIONAL MARKET FORECAST

10.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast
10.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country
  10.2.3 Asia Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Region
  10.2.4 South America Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Cell and Gene Therapy Supply Chain and Logistics by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Type (2025-2030)
11.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell and Gene Therapy Supply Chain and Logistics Market Size Comparison by Region (M USD)
Table 5. Global Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) by Company (2019-2024)
Table 6. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Supply Chain and Logistics as of 2022)
Table 8. Company Cell and Gene Therapy Supply Chain and Logistics Market Size Sites and Area Served
Table 9. Company Cell and Gene Therapy Supply Chain and Logistics Product Type
Table 10. Global Cell and Gene Therapy Supply Chain and Logistics Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Cell and Gene Therapy Supply Chain and Logistics
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Cell and Gene Therapy Supply Chain and Logistics Market Challenges
Table 18. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (M USD)
Table 19. Global Cell and Gene Therapy Supply Chain and Logistics Market Size (M USD) by Type (2019-2024)
Table 20. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Type (2019-2024)
Table 21. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Type (2019-2024)
Table 22. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application
Table 23. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2019-2024) & (M USD)
Table 24. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2019-2024)
Table 25. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Application (2019-2024)
Table 26. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2019-2024) & (M USD)
Table 27. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Region (2019-2024)
Table 28. North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2019-2024) & (M USD)
Table 31. South America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2019-2024) & (M USD)
Table 33. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 34. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 35. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics SWOT Analysis
Table 37. Be The Match BioTherapies Business Overview
Table 38. Be The Match BioTherapies Recent Developments
Table 39. Biocair Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 40. Biocair Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 41. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics SWOT Analysis
Table 43. Biocair Business Overview
Table 44. Biocair Recent Developments
Table 45. Marken Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 46. Marken Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 47. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics SWOT Analysis
Table 49. Marken Business Overview
Table 50. Marken Recent Developments
Table 51. World Courier Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 52. World Courier Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 53. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 54. World Courier Business Overview
Table 55. World Courier Recent Developments
Table 56. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 57. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 58. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 59. MAK-SYSTEM Business Overview
Table 60. MAK-SYSTEM Recent Developments
Table 61. Cryoport Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 62. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 63. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Cryoport Business Overview
Table 65. Cryoport Recent Developments
Table 66. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 67. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 68. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Brooks Life Sciences Business Overview
Table 70. Brooks Life Sciences Recent Developments
Table 71. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 72. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 73. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Clarkston Consulting Business Overview
Table 75. Clarkston Consulting Recent Developments
Table 76. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 77. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 78. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Hypertrust Patient Data Care Business Overview
Table 80. Hypertrust Patient Data Care Recent Developments
Table 81. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 82. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 83. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Haemonetics Business Overview
Table 85. Haemonetics Recent Developments
Table 86. MasterControl Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 87. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 88. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 89. MasterControl Business Overview
Table 90. MasterControl Recent Developments
Table 91. TraceLink Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 92. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 93. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 94. TraceLink Business Overview
Table 95. TraceLink Recent Developments
Table 96. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 97. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 98. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 99. SAVSU Technologies Business Overview
Table 100. SAVSU Technologies Recent Developments
Table 101. TrakCel Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 102. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 103. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 104. TrakCel Business Overview
Table 105. TrakCel Recent Developments
Table 106. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 107. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 108. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Title21 Health Solutions Business Overview
Table 110. Title21 Health Solutions Recent Developments
Table 111. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 112. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 113. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 114. sedApta Group Business Overview
Table 115. sedApta Group Recent Developments
Table 116. Vineti Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 117. Vineti Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 118. Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 119. Vineti Business Overview
Table 120. Vineti Recent Developments
Table 121. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 122. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 123. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 124. Stafa Cellular Therapy Business Overview
Table 125. Stafa Cellular Therapy Recent Developments
Table 126. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 127. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 128. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 129. Thermo Fisher Scientific Business Overview
Table 130. Thermo Fisher Scientific Recent Developments
Table 131. McKesson Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 132. McKesson Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 133. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 134. McKesson Business Overview
Table 135. McKesson Recent Developments
Table 136. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Basic Information
Table 137. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product Overview
Table 138. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (M USD) and Gross Margin (2019-2024)
Table 139. BioLife Solutions Business Overview
Table 140. BioLife Solutions Recent Developments
Table 141. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Region (2025-2030) & (M USD)
Table 142. North America Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2025-2030) & (M USD)
Table 144. Asia Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Region (2025-2030) & (M USD)
Table 145. South America Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Type (2025-2030) & (M USD)
Table 148. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Industrial Chain of Cell and Gene Therapy Supply Chain and Logistics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy Supply Chain and Logistics Market Size (M USD), 2019-2030
Figure 5. Global Cell and Gene Therapy Supply Chain and Logistics Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (M USD)
Figure 10. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Company in 2023
Figure 11. Cell and Gene Therapy Supply Chain and Logistics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy Supply Chain and Logistics Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Type
Figure 15. Market Size Share of Cell and Gene Therapy Supply Chain and Logistics by Type (2019-2024)
Figure 16. Market Size Market Share of Cell and Gene Therapy Supply Chain and Logistics by Type in 2022
Figure 17. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Application
Figure 20. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2019-2024)
Figure 21. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Application in 2022
Figure 22. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Region (2019-2024)
Figure 24. North America Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Country in 2023
Figure 26. U.S. Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Cell and Gene Therapy Supply Chain and Logistics Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Cell and Gene Therapy Supply Chain and Logistics Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Country in 2023
Figure 31. Germany Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Region in 2023
Figure 38. China Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (M USD)
Figure 44. South America Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Country in 2023
Figure 45. Brazil Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Cell and Gene Therapy Supply Chain and Logistics Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Type (2025-2030)
Figure 57. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Application (2025-2030)


More Publications